Inmith 1500 Injection contains Methylcobalamin 1500 mcg, a biologically active form of vitamin B12 essential for neurological function and hematopoiesis. This injectable formulation is indicated for the treatment of vitamin B12 deficiency, which may present as pernicious anemia, neuropathies, or other conditions associated with impaired cobalamin metabolism. Methylcobalamin plays a critical role in DNA synthesis, red blood cell formation, and maintenance of the myelin sheath surrounding nerves, thereby supporting nerve regeneration and repair. Inmith 1500 Injection is commonly administered intramuscularly or subcutaneously under medical supervision to rapidly restore adequate vitamin B12 levels in patients with malabsorption syndromes, chronic alcoholism, or dietary deficiency. The dosage and duration of therapy should be individualized based on the severity of deficiency and clinical response. Adverse effects are generally rare but may include mild injection site reactions, allergic responses, or transient gastrointestinal disturbances. Caution is advised in patients with known hypersensitivity to cobalamin or any component of the formulation. Monitoring of hematological parameters and neurological status is recommended during treatment to assess efficacy and detect potential adverse effects. Inmith 1500 Injection provides an effective therapeutic option for correcting vitamin B12 deficiency and preventing associated neurological and hematological complications.